More NewsRead More
Chimerix Presents Update on Preliminary Data From AdVise Study of Brincidofovir for Adenovirus Infection at BMT Tandem Meetings
February 12, 2015
from PR Newswire
Chimerix Focusing Efforts on CMV and Adenovirus Pivotal Trials
January 30, 2015
Chimerix Receives Notice of Allowance for Brincidofovir Composition of Matter Patent Extending Exclusivity to 2034
January 12, 2015
Chimerix Provides Update on Brincidofovir Pivotal Phase 3 AdVise Trial for the Treatment of Adenovirus
January 08, 2015
Top Buys by Directors: Mario's $521.9K Bet on CMRX
February 26, 2015
from Market News Video
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here